Researchers developed a humanized mouse model that better predicts how antibody drugs interact with the immune system. The ...

Scientists at Ghent University have created a mouse model that incorporates human versions of the receptors that recognize the fragment crystallizable (Fc) region of immunoglobulin G (IgG), one of the ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced a major, ...

Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic ...

Researchers say an immunotherapy they used represents a significant step forward and could lead to new treatment options, even for other forms of cancer ...

A new study from Karolinska Institutet shows that damage to small blood vessels in the hereditary disease CADASIL may disrupt ...

Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.

GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: ...

The difficulty is that EBV lives latently in B cells in the blood at a frequency, in most immunocompetent individuals, of about 1 in 100,000 to 1 in a million. That level of infection is below the ...